Randomized Phase II Trial Comparing Docetaxel with weekly Paclitaxel and Carboplatin in Elderly Patients with Non-Small Cell Lung Cancer

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2010
INTERVENTION: Docetaxel alone Weekly paclitaxel and carboplatin CONDITION: Non‐small cell lung cancer PRIMARY OUTCOME: Response rate INCLUSION CRITERIA: Non‐small cell lung cancer Chemotherapy‐naive Clinical Stage IIIB, IV, or post‐operative reccurence ECOG performance status 0,1 with mesurable lesion with adequate organ function with written informed concent
Epistemonikos ID: a31eb0debbff98524b620052ba1419f33114fb85
First added on: Aug 22, 2024